ALKLH.PA KLEA HOLDING

Healthcare Diagnostics & Research Euronext Paris
0.1578 EUR
Close of Nov 7, 2026
0.1040 0.2560
Market cap
EUR 48.2M
P/E
-
P/B
1.73x
ROE
8.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is ALKLH.PA undervalued?

Graham number

The Graham number of KLEA HOLDING cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

KLEA HOLDING fundamental analysis

No fundamental analysis for KLEA HOLDING yet.

KLEA HOLDING stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About KLEA HOLDING

Klea Holding SA, together with its subsidiaries, develops health technologies and services in France, the United Arab Emirates, and Saudi Arabia. It operates digitalized medical centers that provide administrative screenings for residency and work visas, preventive health check-ups, and medical fitness tests under the Smart Salem brand. In addition, the company engages in the production of pharmaceuticals. The company was formerly known as Visiomed Group SA and changed its n…

Full company profile